Meno Belly, BMI, and Body Composition in Menopause: What Women 45–60 in Eden Prairie Need to Know
Whether in my office or at the hospital, women say the same thing “My jeans fit differently, but the scale hasn’t moved.” If your midsection changed during perimenopause or menopause while your BMI (body mass index) still looks normal, you are not imagining it and you are not alone.
Here is the short version: “Meno belly” is a shift toward abdominal and visceral fat (fat around your organs) that often appears in midlife. BMI can miss this risk. Body composition and waist circumference measures give better insight. GLP‑1 medications are FDA‑approved for people with obesity (BMI ≥30) or overweight (BMI ≥27) with certain health conditions. For women with a normal BMI, we focus on targeted nutrition, resistance training, sleep, hormone therapy, and reducing metabolic risk. We also consider medications.
I’m Margaret Enadeghe, M.D., MSCP, FACOG, DABOM—Double Board Certified in Obesity Medicine and Obstetrics & Gynecology, and Menopause Certified. For more than 11 years, I’ve helped women address this exact issue. In my practice, many women have a BMI of 25–29 but show high body fat percentage and elevated visceral fat on bioimpedance scans. Some also have high cholesterol or high blood pressure. The number on the scale does not tell the full story. If you want a data‑driven evaluation, our clinic offers comprehensive menopause and metabolic care, including in‑office body composition testing. Learn more at The WoMn Clinic and our personalized weight and metabolic health services.
Is “Meno Belly” Normal in Perimenopause and Menopause?
Yes. Many women notice more fat around the abdomen during perimenopause and menopause, even if their weight stays the same. This shift often reflects more visceral fat, which sits around the organs and can affect health. As we age our fat mass increases and our lean muscle mass decrease. So at the same weight, our bodies can look very different on the inside.
You can change that trend. The right plan targets visceral fat while protecting your muscle. The goal is not a lower number on the scale; it’s better body composition and lower risk. I tell my patients our goal is to be strong and metabolically healthy.
Understand “Meno Belly” So You Can Target What Matters
What “meno belly” really is
A common term for central (abdominal) fat gain many women notice in perimenopause and menopause.
A shift toward visceral fat which is fat around your organs, not just the soft fat under the skin.
It can happen even when BMI looks normal, which is why BMI can be misleading.
Can my BMI be normal yet my health risk go up?
Yes. BMI is a height‑to‑weight ratio. It doesn’t separate fat from muscle or show where fat sits.
A woman with a BMI of 22 can still carry high body fat, especially around the abdomen, which increases cardiometabolic risk.
Body composition testing and simple waist circumference measures add important context to BMI for midlife women.
Why Abdominal Fat Increases in Menopause and Why It Matters
What causes the shift?
Estrogen declines during the menopause transition and change how and where the body stores fat, favoring the abdomen.
Menopause can also affect insulin sensitivity, sleep, and energy use. These changes influence appetite, cravings, and how your body handles calories.
Stress, less muscle mass, and changes in routine or recovery can further encourage central fat storage.
Why is visceral fat different?
Visceral fat is metabolically active tissue linked to higher risks for high blood pressure, abnormal cholesterol, fatty liver, and insulin resistance.
Even modest increases in waist size or waist‑to‑height ratio can raise risk, independent of BMI.
For women, a growing waistline despite a normal BMI deserves evaluation. See overviews and measurement guidance:
How We Measure What Matters in Menopause
The tools we use and why we use them:
Bioimpedance analysis (BIA): Estimates body fat percentage, skeletal muscle mass, and a visceral fat index. Hydration and device quality affect accuracy, but protocol‑driven, repeated measures show helpful trends. Review of BIA strengths and limits .
Waist metrics: Waist circumference and waist‑to‑height ratio are simple, low‑cost indicators of central fat and cardiometabolic risk. A waist circumference of greater than 35 inches in women carries a higher metabolic risk.
DXA: Dual‑energy X‑ray absorptiometry provides gold‑standard data on fat and lean mass distribution, including visceral fat estimates.
Metabolic labs: Lipid panel, Apo B, Lipoprotein(a), fasting glucose/HbA1c, liver enzymes (for fatty liver risk), and insulin or other markers build a complete risk picture.
Menopause symptom and history review: Hot flashes, sleep, stress, and activity shape body composition and guide a practical plan.
Are GLP‑1 Medications Right for Meno Belly?
What do the guidelines say?
GLP‑1 receptor agonists for chronic weight management are FDA‑approved for adults with BMI ≥30, or BMI ≥27 with at least one weight‑related condition such as high blood pressure, dyslipidemia, or type 2 diabetes.
The Endocrine Society emphasizes a strong lifestyle foundation and careful selection when using medications (https://www.endocrine.org/clinical-practice-guidelines/pharmacological-management-of-obesity).
For women with a normal BMI (<25), GLP‑1 medications are not approved for weight management. Off‑label use requires caution, clinical judgment, clear rationale, and close medical supervision.
How I counsel my patients
If your BMI is 25–29.9 with a weight‑related condition—like elevated LDL, high blood pressure, impaired fasting glucose, fatty liver, or sleep apnea—we discuss FDA‑labeled options, including GLP‑1 agents, after a thorough risk‑benefit review.
If your BMI is normal but your body composition shows more visceral fat and rising metabolic risk, this is more nuanced. We start with a plan that protects lean mass and reduces central fat: protein‑forward nutrition, progressive resistance training, sleep support, and reduced alcohol and ultra‑processed foods. We discuss novel (non-FDA approved) approaches such as micro-dosing GLP-1s to affect fat loss.
We discuss the benefits of hormone therapy in helping with fat redistribution away from the abdomen. Recent studies have shown a 35% increase in weight loss when GLP-1s are used with hormone therapy.
Safety notes you should know
GLP‑1 medications can cause gastrointestinal side effects and are contraindicated for certain thyroid and pancreatic conditions. They require careful dose increases and monitoring.
No medication replaces strength training and adequate protein, which protect muscle in midlife.
How We Tackle Stubborn Abdominal Fat at The WoMn Clinic
As a Double Board‑Certified Obesity Medicine and OB/GYN specialist, I built our process around precision, not guesswork.
Step 1: Comprehensive assessment
Menopause and metabolic intake: Symptoms, medical history, medications, sleep, stress, and activity.
In‑office BIA: I use one of the two trusted brands: InBody. Body fat %, skeletal muscle mass, visceral fat index—repeated under consistent conditions for reliable trends.
Anthropometrics: Waist circumference and waist‑to‑height ratio.
Lab evaluation: Metabolic labs listed above and additional tests vitamin D, B12, ferritin and thyroid studies.
Step 2: Personalized strategy to reduce visceral fat and protect muscle
Protein target: Most women do well with 1.2–1.6 g protein per kilogram of ideal body weight per day. Spread protein across meals to support muscle. Most of us have to use a protein drink to reach these goals.
Resistance training: Two to four sessions weekly focused on major muscle groups—squats, hinges, pushes, pulls—with progressive overload to rebuild lean mass.
Smart cardio: Aim for 150+ minutes of moderate activity weekly, plus daily movement like walking the Purgatory Creek boardwalk or laps at the Community Center track. Some women incorporate movement at their desk with a walking pad.
Fiber and quality carbs: Get 25–35 g/day from vegetables, legumes, berries, and whole grains to aid satiety and stable blood sugar.
Alcohol and added sugars: Reduce to lower drivers of visceral fat.
Sleep and stress: Improve sleep continuity and manage stress, both of which influence central fat.
Menopause care: Encourage menopause hormone therapy
Step 3: Medications when appropriate
BMI ≥30 or BMI ≥27 with comorbidities: FDA‑approved anti‑obesity medications, including GLP‑1 agents, alongside the lifestyle foundation.
Normal BMI with metabolic risk: We focus on lifestyle, symptom‑directed MHT, and close monitoring. If considering off‑label therapy, we review evidence, benefits, and risks, then proceed only when safe and aligned with your goals.
Step 4: Ongoing data‑driven follow‑up
Track body composition every 6–12 weeks to ensure fat decreases while muscle holds steady or improves.
Recheck labs to monitor lipids, glucose control, and liver health.
Adjust training, nutrition, and medications based on your outcomes and how you feel.
Practical Steps You Can Start This Week
Check your waist‑to‑height ratio: Aim for a waist measurement less than half your height. This simple marker often reflects central fat better than BMI.
Build your plate around protein and plants: Target 25–35 g of protein per meal with vegetables, legumes, and fiber‑rich carbs to steady appetite.
Lift weights two to three times weekly: Use compound movements. Start with bodyweight, bands, or light dumbbells and progress gradually.
Walk daily: Accumulate 7,000–10,000 steps or simply move more to break up long sitting and use nearby trails like Bryant Lake Regional Park.
Audit alcohol: Reducing to 0–3 drinks weekly can meaningfully lower visceral fat over time.
Sleep as a skill: Protect 7–8 hours. Keep a consistent routine and a cool, dark room for better metabolic health.
Track trends, not just weight: Use a tape measure at home or schedule periodic in‑clinic Body Composition to track waist and body composition.
Partner with a clinician: If you have high blood pressure, high cholesterol, elevated fasting glucose, or a family history of heart disease, a personalized plan matters.
When Should You See a Doctor?
Your waist is growing even though your weight stays stable.
Your BMI is normal, but you have high cholesterol, high blood pressure, or rising blood sugar.
You feel stuck despite exercise and careful eating, or menopause symptoms disrupt sleep and daily life.
You want a safe, evidence‑based review of GLP‑1 options and Menopausal hormone therapy.
Early evaluation helps you act before problems grow. You deserve a plan tailored to your body and goals.
Common Questions for Eden Prairie Women
Do you offer body composition testing on site?
Yes. We use clinical‑grade bioimpedance analysis (BIA) to track body fat %, skeletal muscle, and a visceral fat index over time.
How accessible is your Eden Prairie clinic?
Our clinic is conveniently located in Eden Prairie with easy, free parking. We also offer telehealth for eligible Minnesota residents. See our website for current directions and hours.
Is this covered by insurance?
We do not process insurance. We provide documentation you can submit to your insurer and accept HSA/FSA. We review expected costs before you begin.
Research and Resources
Mayo Clinic: Why belly fat matters and how waist size relates to risk
Endocrine Society: Pharmacological management of obesity guidelines
Review of bioimpedance for body composition: strengths and limitations in clinical use
The Expert Perspective and Your Next Step
As a clinician who specializes in menopause and obesity medicine, I’ve watched many women reclaim their health by shifting focus from the bathroom scale to the metrics that matter: visceral fat, lean mass, waist measures, and metabolic markers. This approach is not a fad. It is a precise, supportive, and sustainable framework that respects how the menopausal body changes and what truly moves the needle.
If “meno belly” affects how you feel, how you move, or what your labs show, a personalized consultation can clarify what’s happening and which options fit your goals and medical history. Schedule a visit with me at The WoMn Clinic to get a clear, compassionate plan grounded in evidence and tailored to you.
This blog post is for educational purposes only and does not replace professional medical advice. Please consult your physician for personalized guidance.